Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Advantage Health
GHK-Cu and Cellular Senescence: Downstream Oxidative Mechanism In aged fibroblasts identified by high SA--gal activity, GHK-Cu reduces SA--gal+ cells from 48% to 28% (41%), p16INK4a mRNA 2832%, and p21WAF1 2226% with 7-day treatment indicating partial reversal of the senescent phenotype
Management: Rotate injection sites daily
The following information is based on ProHealth Longevity's publicly available product materials, along with referenced preclinical research and current regulatory context
US$ 26.16
US$ 22.37
US$ 22.45
US$ 25.70
US$ 25.48
US$ 23.15
US$ 20.63
US$ 25.52
US$ 22.70
US$ 22.08
